Labeled compounds for proteasome inhibition

Details for Australian Patent Application No. 2005295183 (hide)

Owner Proteolix, Inc.

Inventors Laidig, Guy J.; Bennett, Mark K.; Lewis, Evan R.; Demo, Susan; Buchholz, Tonia J.; Smyth, Mark S.

Agent Shelston IP

Pub. Number AU-A-2005295183

PCT Pub. Number WO2006/045066

Priority 60/674,834 26.04.05 US; 60/620,573 20.10.04 US

Filing date 19 October 2005

Wipo publication date 27 April 2006

International Classifications

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/045066 Priority application(s): WO2006/045066

22 July 2010 Alteration of Name

  The name of the applicant has been altered to Onyx Therapeutics, Inc. Amendments

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295188-Biomolecular recognition of crystal defects

2005295179-Power-on-reset of elevator controllers